| Issue |
Section |
Title |
File |
| Vol 20, No 17 (2013) |
Articles |
Znachenie molekulyarnykh markerov pri vybore neoad\"yuvantnoy khimioterapii mestno-rasprostranennogo raka molochnoy zhelezy |
|
| Vol 23, No 17 (2016) |
Articles |
RESOLUTION SUMMARIZING THE RESULTS OF THE EXPERT COUNCIL "MODERN APPROACHES TO THE TREATMENT OF HER2-NEGATIVE METASTATIC BREAST CANCER. PROSPECTS FOR THE USE OF ERIBULIN AS A PART OF COMBINATION THERAPY FOR BREAST CANCER" |
|
| Vol 25, No 7 (2018) |
Articles |
SYSTEMIC THERAPY FOR ADVANCED OVARIAN CANCER IN BRCA1 MUTATION CARRIERS -NEW THERAPEUTIC APPROACHES: RESULTS OF A PROSPECTIVE NON-RANDOMIZED MULTI-CENTER STUDY |
|
| Vol 25, No 7 (2018) |
Articles |
PROSPECTIVE II PHASE STUDY ON THE EVALUATION OF THE EFFICACY OF MONOTHERAPY WITH CETUXIMAB AS THE FIRST-LINE TREATMENT FOR PATIENTS WITH METASTATIC COLORECTAL CANCER WITH WILD-TYPE KRAS, NRAS, AND BRAF GENES |
|
| Vol 26, No 7 (2019) |
Articles |
PEComas: what are the treatment options? Literature review and personal experience |
|
| Vol 26, No 12 (2019) |
Articles |
A prospective non-randomized trial: the use of platinum-containing chemotherapy with mitomycin for relapses of BRCA1-associated ovarian cancer |
|
| Vol 26, No 12 (2019) |
Articles |
Evaluation of RETmRNA expression in malignant tumors of the salivary glands |
|
| Vol 27, No 7 (2020) |
Articles |
Rare immuno-mediated adverse events: literature review |
|
| Vol 28, No 7 (2021) |
Articles |
Experience of using prolgolimab in real clinical practice |
|
